Annals of the Rheumatic Diseases (ARD)

is a leading rheumatology journal from EULAR, publishing original research, reviews and recommendations

Impact Factor: 20.3
Citescore: 35
All metrics >>

Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal covering all aspects of rheumatology, which includes the full spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research, including the most important recommendations for the management of various conditions.

Free lay summaries are provided for selected research articles and all EULAR recommendations. You can keep up with the latest news via X and Facebook.

Listen to the ARD Podcast and subscribe in all podcast platforms, including Apple Podcasts, Amazon Music and Spotify.

Editor-in-Chief: Professor Josef Smolen, Medical University of Vienna, Austria
Editorial team

ARD is a Plan S compliant Transformative Journal.

Current Issue

Latest EULAR Recommendations

Involvement of patient research partners in rheumatology research

EULAR recommendations for the involvement of patient research partners in rheumatology research: 2023 update

Management of psoriatic arthritis with pharmacological therapies

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

3D rendered photo of rheumatological disease affecting the hand

Imaging in diagnosis and management of CiAs in clinical practice

2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice

Non-pharmacological core management of hip and knee osteoarthritis

EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update

Authors

Annals of the Rheumatic Diseases considers unsolicited submissions of a variety of article types, including original research articles (extended and concise reports), viewpoints, and letters to the Editor.

The Author Information section provides general guidelines and requirements for specific article types.

Information is also provided on editorial policies and open access.

Author information Submit a paper

Latest Articles

Osteoarthritis:

Cell and transcriptomic diversity of infrapatellar fat pad during knee osteoarthritis

7 October 2024

Rheumatoid arthritis:

Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness

4 October 2024

Rheumatoid arthritis:

Association of methotrexate polyglutamates concentration with methotrexate efficacy and safety in patients with rheumatoid arthritis treated with predefined dose: results from the MIRACLE trial

4 October 2024

Vasculitis:

Age, anticoagulants, hypertension and cardiovascular genetic traits predict cranial ischaemic complications in patients with giant cell arteritis

3 October 2024

Osteoarthritis:

Comparison of definitions of early knee osteoarthritis for likelihood of progression at 2-year and 5-year follow-up: the Multicenter Osteoarthritis Study

3 October 2024

Articles by Topic

View full list

Recommendations

The EULAR Standing Committees regularly establish and publish recommendations for the treatment of various rheumatic disorders. Each of these recommendations is developed by a group of specialists in their field.

All EULAR recommendations are free to access.

Each recommendation also has an accompanying lay summary, which is also free to access.

Video Abstract

m6A RNA methylation controls salivary gland epithelial cell function and has a protective role in Sjögren’s disease

18 September 2024

Conclusions: Impairment of m6A modifications in SGEC in response to inflammatory triggers favour the formation of dsRNA, potentially amplifying the interferon loop and contributing to SjD pathogenesis.

Find out more

Altmetrics

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
12 October 2023

Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis
30 November 2022

Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials
17 January 2023

Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the ‘JAK-pot’ collaboration
15 June 2022

2023 ACR/EULAR antiphospholipid syndrome classification criteria
28 August 2023

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
10 November 2022

Jobs

Consultant Cardiac Surgeon

London

We are recruiting a substantive Full Time Consultant Cardiac Surgeon to work alongside our existing cardiac surgeons

Recruiter: St George's University Hospitals NHS Foundation Trust

Consultant Psychiatrist

Atherton

Introduction We are looking for an enthusiastic colleague to join the team at the Spinney Hospital; Greater Manchester, to deliver high-quality clinical service in our...

Recruiter: Elysium Healthcare

Consultant Anaesthetist

Elgin, Scotland

This full-time post will primarily be based at Dr Gray’s Hospital. Specialist interests will be encouraged and there may be an opportunity

Recruiter: NHS Grampian

Consultant Oncologist (Medical or Clinical)

Cardiff (Caerdydd)

We are looking for a Consultant Oncologist (Medical or Clinical) with an interest in Sarcoma to lead and develop the Sarcoma service

Recruiter: Velindre University NHS Trust

Consultant Psychiatrist - North Somerset Hospital Liaison

Weston-Super-Mare

Are you looking for your next role as a dynamic clinical leader in Acute Hospital Mental Health Liaison?

Recruiter: Avon and Wiltshire Mental Health Partnership NHS Trust